Atypical femoral fractures and current management
With the rapid increase in patients receiving bisphosphonates (BPs) for treating osteoporosis, one of the clinical complications associated with its long-term use is atypical femoral fractures (AFFs). Although the absolute risk for AFFs is low and it was a consensus that AFFs were acceptable compare...
Main Authors: | Nianye Zheng, Ning Tang, Ling Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-10-01
|
Series: | Journal of Orthopaedic Translation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214031X1630050X |
Similar Items
-
Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy
by: Dávid Dózsai, et al.
Published: (2020-09-01) -
Comparison of bone turnover suppression in atypical femoral fractures and osteoporotic hip fractures
by: Joosuk Ahn, et al.
Published: (2024-08-01) -
Intermittent Parathyroid Hormone Accelerates Stress Fracture Healing More Effectively Following Cessation of Bisphosphonate Treatment
by: Mahmoud M Bakr, et al.
Published: (2020-09-01) -
Bisphosphonate-induced atypical femoral shaft fracture: A case report
by: Ameer Mustafa Farrukh, et al.
Published: (2023-11-01) -
Incidence of Atypical Femoral Fracture and Its Mortality in a Single Center in Singapore
by: Linsey Gani, et al.
Published: (2021-08-01)